IGM Biosciences Inc.

AI Score

0

Unlock

1.70
-0.01 (-0.58%)
At close: Jan 15, 2025, 11:54 AM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -246.42M -221.10M -165.16M -81.36M -43.13M -22.71M -11.05M
Depreciation & Amortization 8.28M 6.08M 4.48M 1.02M 597.00K 278.00K 161.00K
Stock-Based Compensation 46.55M 44.71M 25.87M 8.45M 1.01M 183.00K 93.00K
Other Working Capital -5.70M 158.17M 5.79M -153.00K -6.99M 2.24M 315.00K
Other Non-Cash Items 6.05M 9.29M 3.24M 2.55M 1.74M 27.00K 287.00K
Deferred Income Tax n/a n/a 781.00K -23.00K -306.00K n/a n/a
Change in Working Capital -6.69M 155.17M 6.45M 2.04M -5.02M 2.18M 443.00K
Operating Cash Flow -192.23M -5.85M -124.34M -67.30M -45.12M -20.04M -10.36M
Capital Expenditures -12.38M -10.21M -13.24M -17.50M -2.34M -788.00K -385.00K
Acquisitions n/a 7.37M -28.70M -57.71M 200.90M n/a n/a
Purchase of Investments -365.04M -540.02M -129.35M -208.56M -208.90M n/a n/a
Sales Maturities Of Investments 445.77M 324.58M 157.41M 283.78M 8.00M n/a n/a
Other Investing Acitivies n/a -7.37M 28.70M 57.71M -200.90M n/a n/a
Investing Cash Flow 68.36M -225.64M 14.82M 57.71M -203.24M -788.00K -385.00K
Debt Repayment n/a n/a n/a n/a 15.00M 5.00M n/a
Common Stock Repurchased n/a n/a -1.55M n/a -324.00K n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 3.01M 1.40M 2.48M -910.00K 348.93M 34.67M 8.07M
Financial Cash Flow 115.07M 219.38M 2.48M 214.78M 282.26M 22.34M 8.07M
Net Cash Flow -8.81M -12.12M -107.05M 205.19M 33.90M 1.50M -2.67M
Free Cash Flow -204.61M -16.06M -137.58M -84.81M -47.45M -20.83M -10.74M